Our present findings suggest triple negative breast cancer specifically as a focus for future clinical studies examining the prognostic significance of tumor cell MMP9, as it may be that the pathways by which tumor MMP9 drives progression and metastasis are most activated or most necessary for this breast cancer subtype. This evidence concerns the gene MMP9 and neoplasm.